Chemical Compound

tolazamide

CAS Registry Number 1156-19-0
Back to search Request a Quote
tolazamide chemical structure
Primary Record

tolazamide

In stock
7,451 g
Purity
99.7 %
CAS
1156-19-0

Compound Identifiers & Properties

CAS
1156-19-0
PubChem CID
5503
SMILES
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2
Canonical SMILES
Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1

Names & Synonyms

  • tolazamide
  • Tolinase
  • Norglycin
  • Tolanase
  • Tolazolamide
  • Diabewas
  • Tolazamida
  • Tolazamidum
  • 1156-19-0
  • Tolamide
  • Semicarbazide
  • Tolonase
  • Ronase
  • Dehydrocorydaline
  • Tolinase (TN)
  • Tolazamidum [INN-Latin]
  • Tolazamida [INN-Spanish]
  • Prestwick_865
  • CCRIS 591
  • NSC-70762
  • NCI-C03327
  • Tolazamide (Standard)
  • 9LT1BRO48Q
  • Spectrum_001269
  • RefChem:56140
  • TOLAZAMIDE [MI]
  • UNII-9LT1BRO48Q
  • 1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea
  • DTXSID3021358
  • C14H21N3O3S
  • AC1L1KHJ
  • TOLAZAMIDE [INN]
  • TOLAZAMIDE [JAN]
  • Opera_ID_1740
  • Prestwick0_000554
  • Prestwick1_000554
  • Prestwick2_000554
  • Prestwick3_000554
  • Spectrum2_001449
  • Spectrum3_001473
  • Spectrum4_000240
  • Spectrum5_001204
  • Lopac-T-2408
  • TOLAZAMIDE [HSDB]
  • TOLAZAMIDE [USAN]
  • N-(p-Toluenesulfonyl)-N'-hexamethyleniminourea
  • U-17835
  • TOLAZAMIDE [VANDF]
  • Tolbutamide EP Impurity C
  • CHEMBL817
  • D09FJB
  • HSDB 3192
  • MLS000028534
  • TOLAZAMIDE [MART.]
  • 1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea
  • CHEBI:9613
  • DTXCID401358
  • EINECS 214-588-3
  • OUDSBRTVNLOZBN-UHFFFAOYSA-N
  • 4-(p-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide
  • NCIOpen2_008361
  • TOLAZAMIDE [USP-RS]
  • TOLAZAMIDE [WHO-DD]
  • CBiol_001918
  • Lopac0_001195
  • Oprea1_061180
  • SCHEMBL34417
  • Tolazamide [USAN:INN:BAN:JAN]
  • U 17835
  • BRN 1323565
  • BSPBio_000627
  • BSPBio_001505
  • BSPBio_003025
  • KBioGR_000225
  • KBioGR_000939
  • KBioSS_000225
  • KBioSS_001749
  • Tolazamide (JAN/USP/INN)
  • MLS001076161
  • NSC70762
  • Pharmacia Brand of Tolazamide
  • DivK1c_000212
  • SPECTRUM1501201
  • SPBio_001317
  • SPBio_002548
  • NSC 70762
  • BPBio1_000691
  • GTPL6847
  • orb1308942
  • orb3025022
  • Tolazamide (JP15/USP/INN)
  • 1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea
  • WLN: T7NTJ AMVMSWR D1
  • TOLAZAMIDE [ORANGE BOOK]
  • BCBcMAP01_000061
  • ERK5-2J21
  • HMS500K14
  • HY-B0920R
  • KBio1_000212
  • KBio2_000225
  • KBio2_001749
  • KBio2_002793
  • KBio2_004317
  • KBio2_005361
  • KBio2_006885
  • KBio3_000449
  • KBio3_000450
  • KBio3_002525
  • ZINC57512
  • A10BB05
  • CID5503
  • MSK7196
  • N-(azepan-1-ylcarbamoyl)-4-methylbenzenesulfonamide
  • MFCD00083504
  • NINDS_000212
  • Bio1_000204
  • Bio1_000693
  • Bio1_001182
  • Bio2_000225
  • Bio2_000705
  • GLXC-21118
  • HMS1361L07
  • HMS1569P09
  • HMS1791L07
  • HMS1921P19
  • HMS1989L07
  • HMS2089L10
  • HMS2092L09
  • HMS2096P09
  • HMS2232L21
  • HMS3259O18
  • HMS3263P11
  • HMS3369L04
  • HMS3402L07
  • HMS3713P09
  • Pharmakon1600-01501201
  • TOLAZAMIDE [USP MONOGRAPH]
  • Tolazamide [USAN:BAN:INN:JAN]
  • BCP23550
  • CID:5503
  • HY-B0920
  • NCI-C-03327
  • Tolazamide [USAN:USP:INN:BAN:JAN]
  • Urea, 1-(hexahydroazepin-1-yl)-3-p-tolylsulfonyl-
  • AI3-50826
  • Tox21_110281
  • Tox21_201507
  • Tox21_300416
  • Tox21_501195
  • 2761AH
  • Benzenesulfonamide, N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-
  • C14-H21-N3-O3-S
  • CCG-39178
  • EBC-13624
  • LS-578
  • MSK7196-100M
  • NCGC00016009-10
  • NSC758149
  • SBB058190
  • Urea, 1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)-
  • SMR000058290
  • AKOS015913823
  • MSK7196-1000M
  • Tox21_110281_1
  • 1-(azepan-1-yl)-3-(4-methylbenzenesulfonyl)urea
  • 1-(azepan-1-yl)-3-(p-tolylsulfonyl)urea
  • ACN-053046
  • CAS-1156-19-0
  • CS-4389
  • DB00839
  • FT61359
  • J3.663C
  • KS-1438
  • LP01195
  • NC00590
  • NSC-758149
  • SDCCGSBI-0051162.P004
  • 4-(p-Tolylsulfonyl)-1,1-hexamethylene
  • IDI1_000212
  • IDI1_033975
  • NCGC00016009-01
  • NCGC00016009-02
  • NCGC00016009-03
  • NCGC00016009-04
  • NCGC00016009-05
  • NCGC00016009-06
  • NCGC00016009-07
  • NCGC00016009-08
  • NCGC00016009-09
  • NCGC00016009-11
  • NCGC00016009-12
  • NCGC00016009-13
  • NCGC00016009-14
  • NCGC00016009-15
  • NCGC00016009-16
  • NCGC00016009-17
  • NCGC00016009-19
  • NCGC00016009-24
  • NCGC00023701-03
  • NCGC00023701-04
  • NCGC00023701-05
  • NCGC00023701-06
  • NCGC00023701-07
  • NCGC00023701-08
  • NCGC00023701-09
  • NCGC00023701-10
  • NCGC00254501-01
  • NCGC00259058-01
  • NCGC00261880-01
  • AK546472
  • CPD000058290
  • DA-68249
  • SAM002564236
  • SID:99222746
  • SBI-0051162.P003
  • T 2408
  • 3-azepan-1-yl-1-(4-methylphenyl)sulfonyl-urea
  • N-[(azepan-1-ylamino)carbonyl]-4-methylbenzenesulfonamide
  • Tolazamide Solution in Methanol, 100ug/mL
  • AB00052247
  • Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methyl-
  • EU-0101195
  • FT-0675268
  • NS00007143
  • ST51015133
  • SW196991-3
  • Tolazamide Solution in Methanol, 1000ug/mL
  • TOLBUTAMIDE IMPURITY C [EP IMPURITY]
  • 5-20-04-00062 (Beilstein Handbook Reference)
  • 1-(Hexahydro-1H-azepin-1-yl)-3-(p-toluenesulfonyl)urea
  • 59866P
  • C71499
  • D00379
  • N-(((Hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methylbenzenesulfonamide
  • AB00052247-15
  • AB00052247_16
  • AB00052247_17
  • N-(p-Toluenesulfonyl)-N'-hexa-methyleniminourea
  • A921617
  • D014042
  • N-[[(Hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methylbenzenesulfonamide
  • SR-01000003105
  • 1-(azepan-1-yl)-3-((4-methylbenzene)sulfonyl)urea
  • 1-(azepan-1-yl)-3-[(4-methylbenzene)sulfonyl]urea
  • 3-(Azepan-1-yl)-1-(4-methylphenyl)Sulfonyl-Urea
  • Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methyl-
  • Q7814101
  • SR-01000003105-2
  • SR-01000003105-4
  • SR-01000003105-5
  • SR-01000003105-8
  • 1-(((((4-Methylphenyl)sulfonyl)amino)carbonyl)amino)azepane
  • 1-(4-Methylphenylsulfonyl)-3-(hexahydro-1H-azepin-1-yl)urea
  • BRD-K32164935-001-06-8
  • BRD-K32164935-001-17-5
  • BRD-K32164935-001-28-2
  • BRD-K32164935-001-29-0
  • BRD-K32164935-001-30-8
  • BRD-K32164935-001-31-6
  • I14-44488
  • F2173-1137
  • Z1575267190
  • 1-[(Azepan-1-ylamino)carbonyl]-4-methylbenzenesulfonamide
  • N-[(Azepan-1-yl)carbamoyl]-4-methylbenzene-1-sulfonamide
  • 1-[(([(4-Methylphenyl)sulfonyl]amino)carbonyl)amino]azepane #
  • 1-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]azepane
  • N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methylbenzenesulfonamide
  • Tolazamide, United States Pharmacopeia (USP) Reference Standard
  • (azaperhydroepinylamino)-N-[(4-methylphenyl)sulfonyl]carboxamide
  • 1-(4-Methyl phenylsulfonyl)-3-(hexahydro-1H-azepin-1-yl)urea
  • Benzenesulfonamide, {N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-}
  • Benzenesulfonamide, N-[[(hexahydro-1-azepinyl)amino]carbonyl]-4-methyl-
  • N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide
  • BENZENESULFONAMIDE, N-[[(HEXAHYDRO-1H-AZEPIN-1YL)AMINO]-CARBONYL]-4-METHYL-
  • 214-588-3
  • Benzenesulfonamide, N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-; Urea, 1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)- (6CI,7CI,8CI); 1-(4-Methylphenylsulfonyl)-3-(hexahydro-1H-azepin-1-yl)urea; 1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea; 1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea; Diabewas; N-(p-Toluenesulfonyl)-N'-hexamethyleniminourea; NSC 70762; Norglycin; Tolanase; Tolazamide; Tolinase; U 17835; Tolbutamide Impurity C